Prestige Consumer Healthcare Inc. (PBH)

NYQ – Real vaqt narxi. Valyuta: USD

52.91

-0.69 (-1.29%)

Bozor ochiq: Aug 12, 2026, 11:56 AM EDT

53.60

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

10.08.2026

Premium Brands Q2 Earnings Call Highlights

Premium Brands TSE: PBH said its revised 2026 outlook reflects timing shifts in U.S. customer programs and the exit of a low-margin Ontario facility, rather than a deterioration in the company's underlying operating assumptions.

09.08.2026

Prestige Consumer Healthcare Q1 Earnings Call Highlights

Prestige Consumer Healthcare NYSE: PBH reported first-quarter fiscal 2027 revenue growth of 6.5%, supported by broad-based category strength, the initial contribution from its Breathe Right acquisition and retailer order timing. The company raised its reported full-year outlook to incorporate Breathe Right and LaCorium Health while maintaining its prior outlook for organic revenue growth.

06.08.2026

Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript

06.08.2026

Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.95 per share a year ago.

06.08.2026

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

TARRYTOWN, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter fiscal 2027 ended June 30, 2026.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

TARRYTOWN, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter fiscal 2027 ended June 30, 2026.

Prestige Consumer Healthcare Inc. (PBH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Prestige Consumer Healthcare Inc. (PBH)

Premium Brands Q2 Earnings Call Highlights

Prestige Consumer Healthcare Q1 Earnings Call Highlights

Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript

Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Videolar

No Data

Press-relizlar

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Premium Brands Q2 Earnings Call Highlights

Prestige Consumer Healthcare Q1 Earnings Call Highlights

Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript

Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Videolar

No Data

Press-relizlar

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Search stocks

Prestige Consumer Healthcare Inc. (PBH)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Prestige Consumer Healthcare Inc. (PBH)

Premium Brands Q2 Earnings Call Highlights

Prestige Consumer Healthcare Q1 Earnings Call Highlights

Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript

Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Videolar

No Data

Press-relizlar

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Premium Brands Q2 Earnings Call Highlights

Prestige Consumer Healthcare Q1 Earnings Call Highlights

Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript

Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Videolar

No Data

Press-relizlar

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results